• Gastrointestinal disorders like inflammatory bowel disease (IBD) are a growing challenge to health care all over the world. They often show non-distinctive clinical symptoms, leading to a complex diagnostic process before effective therapy can start
  • Detection of calprotectin in stool samples is a non-invasive and highly-specific indicator for intestinal inflammation and contributes significantly to the differential diagnosis of irritable bowel syndrome (IBS)